GO:0005846 nuclear cap binding complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005846 defines the nuclear cap binding complex (CBC), a conserved heterodimeric protein complex that binds the 5' terminal m7G cap of nascent RNA polymerase II transcripts.
• CBC is composed of two core subunits, CBP20 (NCBP2) and CBP80 (NCBP1), and functions in pre-mRNA splicing, 3'-end formation, and nuclear export.
• CBC interacts with numerous partners, including the TREX complex, splicing factors, and the cap-binding complex interacting protein NIP1, to coordinate gene expression.
• Beyond RNA processing, CBC influences transcription elongation and is implicated in abiotic stress responses in plants and in translation initiation.
• Dysregulation of CBC components has been linked to cancer, neurodegeneration, and developmental disorders, making it a target for CRISPR-based disease modeling.
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to study CBC genes and their roles in disease.
Description
The nuclear cap binding complex (CBC) is a conserved heterodimeric protein complex that binds the 5' terminal cap structure m7G(5')ppp(5')N of nascent eukaryotic RNA polymerase II transcripts, including pre-mRNA and U snRNA. This complex, defined by the Gene Ontology term GO:0005846, is essential for coupling transcription with RNA processing events such as pre-mRNA splicing, 3'-end formation, and nuclear export. CBC consists of two core subunits, CBP20 and CBP80, which together recognize the cap and serve as a platform for recruiting numerous processing factors. Researchers study CBC because it sits at the nexus of gene expression regulation, influencing not only RNA fate but also transcription elongation and translation initiation. Its roles extend to stress responses in plants and to human diseases, including cancer and neurological disorders. Understanding CBC function requires precise genetic tools, and CRISPR-based models are increasingly used to dissect its molecular mechanisms. This article provides a comprehensive overview of GO:0005846, covering its definition, structure, molecular functions, key genes, disease associations, and research methods, with a focus on how CRISPR gene editing can accelerate discoveries.
nuclear cap binding complex At A Glance
| GO ID | GO:0005846 |
|---|---|
| GO term | nuclear cap binding complex |
| Ontology | cellular_component |
| Synonym | CBC, mRNA cap binding complex, NCBP-NIP1 complex, nuclear CBC, snRNA cap binding complex |
| Major function | Binds 5' cap of RNA polymerase II transcripts; involved in pre-mRNA splicing, 3'-end formation, and RNA nuclear export |
| Core subunits | CBP20 (NCBP2) and CBP80 (NCBP1) |
| Subcellular location | Nucleus |
| Conservation | Conserved across eukaryotes |
| Associated processes | Transcription, RNA processing, RNA export, translation initiation |
What Is GO:0005846?
The nuclear cap binding complex (CBC) is a conserved heterodimeric protein complex that specifically binds to the 5' terminal cap structure m7G(5')ppp(5')N of nascent RNA polymerase II transcripts, such as pre-mRNA and U snRNA. It is composed of two proteins, CBP20 and CBP80, and operates in the nucleus to facilitate pre-mRNA splicing, 3'-end formation, and RNA nuclear export. The complex is also known by synonyms including CBC, mRNA cap binding complex, NCBP-NIP1 complex, nuclear CBC, and snRNA cap binding complex.
Why Is nuclear cap binding complex Important in Cell Biology?
The nuclear cap binding complex is a central hub that coordinates multiple steps of gene expression, from transcription to RNA processing and export. Its ability to bind the cap structure of nascent transcripts allows it to recruit factors that determine RNA fate, making it essential for cellular homeostasis. Dysregulation of CBC components has been linked to various human diseases, including cancer and neurodegeneration, and its roles in stress responses highlight its broader biological significance. Therefore, understanding CBC function is critical for both basic biology and therapeutic development.
• CBC couples transcription with pre-mRNA splicing and 3'-end processing, ensuring proper gene expression.
• It mediates nuclear export of mRNA and U snRNA, influencing the cytoplasmic availability of transcripts.
• CBC interacts with the TREX complex and other factors to coordinate export and surveillance.
• It plays a role in translation initiation, linking nuclear cap binding to cytoplasmic protein synthesis.
• In plants, CBC is involved in abiotic stress responses, including salt and drought tolerance.
• Dysregulation of CBC components is associated with cancer, neurodegeneration, and developmental defects.
• CBC is a target for antiviral strategies because some viruses hijack cap-binding machinery.
• Studying CBC provides insights into RNA metabolism and gene regulation networks.
• CRISPR screens can identify CBC-dependent pathways and synthetic lethal interactions.
• CBC components are potential biomarkers and therapeutic targets in oncology.
What Happens During nuclear cap binding complex?
Cap Recognition and Binding
In simple terms: The complex grabs the special chemical tag at the start of new RNA molecules.
The nuclear cap binding complex recognizes and binds the 5' terminal m7G cap structure of nascent RNA polymerase II transcripts. This binding is mediated by the CBP20 subunit, which directly interacts with the cap, while CBP80 stabilizes the interaction and provides a platform for protein-protein interactions. The binding occurs co-transcriptionally, as soon as the cap is synthesized.
Coupling to Pre-mRNA Splicing
In simple terms: After grabbing the RNA, the complex helps cut and paste the RNA to remove non-coding parts.
CBC promotes efficient pre-mRNA splicing by recruiting splicing factors and interacting with the spliceosome. It facilitates the recognition of the 5' splice site and enhances the assembly of the spliceosomal complex, thereby influencing alternative splicing decisions. This coupling ensures that only properly capped transcripts are spliced.
3'-End Formation and Polyadenylation
In simple terms: The complex also helps to properly finish the tail end of the RNA molecule.
CBC is involved in 3'-end formation by stimulating cleavage and polyadenylation of pre-mRNA. It interacts with cleavage and polyadenylation specificity factor (CPSF) and other factors to ensure correct termination and poly(A) tail addition. This function is critical for mRNA stability and export.
Nuclear Export of RNA
In simple terms: The complex acts like a passport, helping RNA leave the nucleus.
CBC mediates the nuclear export of mRNA and U snRNA by recruiting export receptors such as CRM1 and the TREX complex. It binds to the cap and interacts with export factors, facilitating the translocation of RNA through nuclear pore complexes. This export is essential for gene expression and is tightly regulated.
Role in Translation Initiation
In simple terms: Even after leaving the nucleus, the complex can help start protein production.
Nuclear cap-binding proteins can remain associated with RNA during export and participate in the first round of translation, a process known as pioneer translation. CBP80 and CBP20 interact with translation initiation factors to promote efficient protein synthesis. This dual role highlights the multifunctionality of CBC.
Key Genes Involved in GO:0005846 nuclear cap binding complex
The nuclear cap binding complex is composed of core subunits and interacts with numerous accessory proteins that modulate its functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NCBP1 (CBP80) | Core subunit of CBC; binds cap and interacts with processing factors | Essential for splicing, export, and translation; knockout leads to embryonic lethality |
| NCBP2 (CBP20) | Core subunit of CBC; directly binds m7G cap | Critical for cap recognition; mutations affect RNA processing |
| NCBP3 | Accessory cap-binding protein; involved in RNA export and stress response | Paralog of NCBP2; implicated in antiviral responses |
| NIP1 (NCBP3) | Interacts with CBC; involved in RNA processing | Modulates CBC functions in splicing and export |
| TREX complex (e.g., ALYREF) | Couples transcription to export; interacts with CBC | Required for efficient mRNA export |
| CRM1 (XPO1) | Nuclear export receptor; interacts with CBC | Mediates export of CBC-bound RNA |
| CPSF (e.g., CPSF1) | Cleavage and polyadenylation factor; interacts with CBC | Required for 3'-end formation |
| SR proteins (e.g., SRSF1) | Splicing factors; recruited by CBC | Influence splice site selection |
| EIF4E | Cytoplasmic cap-binding protein; functional counterpart | Contrasts with nuclear CBC in translation |
| PHAX | Adaptor for U snRNA export; interacts with CBC | Essential for snRNA nuclear export |
| RNMT | RNA guanine-7 methyltransferase; creates cap | Works upstream of CBC |
| RNGTT | RNA guanylyltransferase; adds cap structure | Required for CBC binding |
| DDX39B (UAP56) | RNA helicase; part of TREX; interacts with CBC | Facilitates export |
| NXF1 (TAP) | Export receptor; interacts with CBC | Mediates mRNA export |
| NCBP2L | Paralog of NCBP2; testis-specific | Potential role in germ cells |
| CBC interacting proteins (e.g., ARS2) | Modulates CBC function in RNA processing | Links CBC to miRNA biogenesis |
How Is nuclear cap binding complex Regulated?
The nuclear cap binding complex is regulated at multiple levels. Its core subunits, NCBP1 and NCBP2, are subject to transcriptional and post-translational regulation. Phosphorylation of CBP80 by CDK kinases modulates its interactions and function during the cell cycle. Additionally, the availability of cap structures and the activity of capping enzymes (RNMT, RNGTT) influence CBC binding. In plants, CBC components are regulated in response to abiotic stress, such as salt and drought, through changes in gene expression and protein modifications. Furthermore, CBC interacts with the mTOR pathway to coordinate translation initiation under nutrient conditions. These regulatory mechanisms ensure that CBC activity is fine-tuned to cellular needs.
nuclear cap binding complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NCBP1 | Cancer (overexpression, poor prognosis) | Knockout in cancer cell lines (e.g., HeLa, MCF7) |
| NCBP2 | Developmental delay, intellectual disability | Knock-in of patient variants in iPSCs |
| NCBP3 | Antiviral response | Knockout in immune cells |
| NCBP1/2 | Neurodegeneration (splicing defects) | Neuronal knockout models |
| CBC interactors (e.g., ARS2) | Cancer, miRNA biogenesis | Overexpression and knockout in tumor models |
Cancer
Dysregulation of CBC components has been observed in various cancers. NCBP1 (CBP80) is overexpressed in some tumors and correlates with poor prognosis. Knockdown of NCBP1 inhibits proliferation and induces apoptosis in cancer cell lines, suggesting a role in tumor growth. Additionally, CBC-mediated splicing alterations can contribute to oncogenic transformation.
Neurodegeneration
Mutations in RNA processing factors, including CBC-associated proteins, have been linked to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy. CBC dysfunction may lead to aberrant splicing and RNA export, contributing to neuronal death. However, direct evidence for CBC mutations in neurodegeneration is still emerging.
Developmental Disorders
Given its essential role in gene expression, CBC is critical for development. Knockout of NCBP1 or NCBP2 in mice results in embryonic lethality, highlighting their non-redundant functions. In humans, rare variants in NCBP2 have been associated with developmental delay and intellectual disability. These findings underscore the importance of CBC in normal development.
Viral Infections
Viruses often hijack cap-binding machinery to promote their replication. For example, influenza virus snatches caps from host transcripts, a process that may involve CBC. Targeting CBC could therefore be a therapeutic strategy against certain viruses.
From nuclear cap binding complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of NCBP1 loss on cell viability? | CRISPR knockout in cancer cell lines |
| How do disease-associated mutations in NCBP2 affect RNA processing? | Point mutation knock-in in HEK293T cells |
| Can we tag endogenous NCBP1 to study its localization? | Knock-in of fluorescent tag (e.g., GFP) at NCBP1 locus |
| What is the impact of NCBP1 overexpression on splicing? | Overexpression of NCBP1 in cell lines |
| Which genes are synthetic lethal with NCBP1? | CRISPR library screening in NCBP1-knockout background |
| How does CBC regulate translation? | Ribo-seq after NCBP1/2 knockdown |
How to Study the nuclear cap binding complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression, splicing, polyadenylation | Assess CBC-dependent RNA processing |
| Ribo-seq | Translation efficiency, ribosome occupancy | Study pioneer translation and CBC role |
| AP-MS | Protein-protein interactions | Map CBC interactome |
| BioID | Proximity-dependent biotinylation | Identify CBC-associated proteins in vivo |
| Fluorescence microscopy | Protein localization and dynamics | Visualize CBC subunits in cells |
| CRISPR knockout | Gene function loss | Determine essentiality of CBC genes |
| CRISPR library screening | Phenotypic screens | Identify synthetic lethal partners |
| CLIP-seq | RNA binding sites | Map CBC binding to transcripts |
RNA Sequencing (RNA-seq)
RNA-seq is used to assess changes in gene expression, splicing patterns, and alternative polyadenylation upon CBC perturbation. Knockdown or knockout of NCBP1/2 followed by RNA-seq reveals widespread effects on pre-mRNA processing. This method can identify CBC-dependent splicing events and 3'-end formation defects.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) has been used to dissect the CBC interactome, identifying numerous partners involved in RNA processing and export. This approach reveals dynamic interactions and can uncover disease-relevant networks. Proximity labeling methods like BioID can also map CBC interactions in living cells.
Ribosome Profiling (Ribo-seq)
Ribo-seq measures translation efficiency and can reveal the role of CBC in pioneer translation. By knocking down CBC components, researchers can assess changes in ribosome occupancy on specific transcripts. This method is particularly useful for understanding the coupling between nuclear cap binding and translation.
Imaging and Localization Studies
Fluorescence microscopy and live-cell imaging of tagged CBC subunits (e.g., GFP-NCBP1) allow visualization of nuclear localization, dynamics, and co-localization with splicing factors. These techniques can reveal how CBC assembles and functions in real-time.
How CRISPR Can Be Used to Study GO:0005846 nuclear cap binding complex
Knockout
CRISPR knockout of NCBP1 or NCBP2 in cell lines results in loss of CBC function, leading to defects in splicing, 3'-end formation, and RNA export. These models are used to study the essentiality of CBC and to identify compensatory pathways. Knockout cells can also be used for synthetic lethal screens.
Point Mutation
Point mutations in NCBP1 or NCBP2 can be introduced to mimic disease-associated variants or to disrupt specific functions, such as cap binding or protein interactions. These models help dissect the molecular mechanisms of CBC in RNA processing and disease.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) or fluorescent proteins at the endogenous NCBP1 or NCBP2 loci allows for real-time imaging and biochemical purification of CBC complexes. This approach preserves endogenous regulation and provides tools for interaction studies.
Overexpression
Overexpression of NCBP1 or NCBP2 in cell lines can be achieved by CRISPR activation (CRISPRa) or by introducing a transgene. Overexpression models are useful to study gain-of-function effects, such as oncogenic roles of NCBP1 in cancer.
How EDITGENE Supports nuclear cap binding complex Research
Researchers studying nuclear cap binding complex-related genes often need to determine whether a candidate gene is causally involved in RNA processing, disease, or stress responses. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation of CBC components and their interactors.
Contact EDITGENE today to design your custom CRISPR model for nuclear cap binding complex research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NCBP2L Knockout HEK293 Cell Line | EDJ-KQ14388 | Human | 392517 | Details Get a Quote |
| NCBP3 Knockout HEK293 Cell Line | EDJ-KQ14389 | Human | 55421 | Details Get a Quote |
| NCBP3 Knockout A-549 Cell Line | EDJ-KQ44558 | Human | 55421 | Details Get a Quote |
| NCBP3 Knockout HCT 116 Cell Line | EDJ-KQ44559 | Human | 55421 | Details Get a Quote |
| NCBP3 Knockout HeLa Cell Line | EDJ-KQ44560 | Human | 55421 | Details Get a Quote |
Frequently Asked Questions About nuclear cap binding complex
What is the nuclear cap binding complex?
The nuclear cap binding complex (CBC) is a conserved heterodimeric protein complex that binds the 5' cap of nascent RNA polymerase II transcripts and functions in pre-mRNA splicing, 3'-end formation, and nuclear export.
What genes are involved in the nuclear cap binding complex?
The core genes are NCBP1 (CBP80) and NCBP2 (CBP20), which encode the two subunits of CBC. Other associated genes include NCBP3, NIP1, and components of the TREX complex.
What is the function of GO:0005846?
GO:0005846 describes the nuclear cap binding complex, which binds the m7G cap of RNA polymerase II transcripts and coordinates RNA processing and export.
How does the nuclear cap binding complex work?
CBC binds the 5' cap of nascent RNA and recruits factors for splicing, 3'-end formation, and export. It also participates in pioneer translation.
What diseases are associated with nuclear cap binding complex mutations?
Mutations in CBC components have been linked to cancer, developmental delay, and neurodegeneration, though direct evidence is still emerging.
What are the subunits of the nuclear cap binding complex?
CBC consists of two core subunits: CBP20 (NCBP2) and CBP80 (NCBP1).
How is the nuclear cap binding complex regulated?
CBC is regulated by phosphorylation, interaction with partners, and cellular signals such as stress and nutrient availability.
What research methods are used to study the nuclear cap binding complex?
Common methods include RNA-seq, Ribo-seq, AP-MS, CRISPR knockout, and imaging of tagged subunits.
Can CRISPR be used to study the nuclear cap binding complex?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect CBC gene functions.
What is the difference between nuclear and cytoplasmic cap binding?
The nuclear cap binding complex (CBC) binds caps in the nucleus and functions in RNA processing, while the cytoplasmic cap-binding protein eIF4E mediates translation initiation.
Conclusion
The nuclear cap binding complex (GO:0005846) is a multifunctional hub that couples transcription with RNA processing, export, and translation. Its core subunits, NCBP1 and NCBP2, are essential for gene expression and are implicated in human diseases ranging from cancer to neurodegeneration. Understanding CBC biology requires precise genetic tools, and CRISPR-based models offer powerful approaches to dissect its mechanisms. EDITGENE provides comprehensive CRISPR services to support research on CBC and its associated pathways, enabling discoveries that could lead to new therapeutic strategies.
References
- 1. Rambout X et al.. 2020. The nuclear cap-binding complex as choreographer of gene transcription and pre-mRNA processing.. Genes Dev 34(17-18):1113-1127 PMID: 32873578
- 2. Kataoka N. 2023. The Nuclear Cap-Binding Complex, a multitasking binding partner of RNA polymerase II transcripts.. J Biochem 175(1):9-15 PMID: 37830942
- 3. Gonatopoulos-Pournatzis T et al.. 2014. Cap-binding complex (CBC).. Biochem J 457(2):231-42 PMID: 24354960
- 5. Daszkowska-Golec A. 2018. Emerging Roles of the Nuclear Cap-Binding Complex in Abiotic Stress Responses.. Plant Physiol 176(1):242-253 PMID: 29142023
- 6. Ryu I et al.. 2017. Translation initiation mediated by nuclear cap-binding protein complex.. BMB Rep 50(4):186-193 PMID: 28088948
- 7. Zhang H et al.. 2022. Cap-binding complex assists RNA polymerase II transcription in plant salt stress response.. Plant Cell Environ 45(9):2780-2793 PMID: 35773782
- 8. Dou Y et al.. 2020. Affinity proteomic dissection of the human nuclear cap-binding complex interactome.. Nucleic Acids Res 48(18):10456-10469 PMID: 32960270
